Vimarsana
Biggest News Aggregation in the World

Page 4 - Nasdaq Bbio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Bbio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Bbio Today - Breaking & Trending Today

Financial Contrast: Equillium (NASDAQ:EQ) versus BridgeBio Pharma (NASDAQ:BBIO) - Vimarsana News

Financial Contrast: Equillium (NASDAQ:EQ) versus BridgeBio Pharma (NASDAQ:BBIO)

BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) and Equillium (NASDAQ:EQ – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, valuation, profitability, institutional ownership, risk and analyst recommendations. Institutional & Insider Ownership 90.9% of BridgeBio Pharma shares […]

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives $40.23 Consensus Target Price from Analysts - Vimarsana News

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives $40.23 Consensus Target Price from Analysts

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) has received an average rating of “Moderate Buy” from the thirteen analysts that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average 12 month price objective among […]

Insider Selling: BridgeBio Pharma, Inc. (NASDAQ:BBIO) Director Sells 2,000 Shares of Stock - Vimarsana News

Insider Selling: BridgeBio Pharma, Inc. (NASDAQ:BBIO) Director Sells 2,000 Shares of Stock

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) Director Randal W. Scott sold 2,000 shares of BridgeBio Pharma stock in a transaction dated Monday, December 18th. The shares were sold at an average price of $40.00, for a total value of $80,000.00. Following the completion of the transaction, the director now owns 9,000 shares of […]

BridgeBio Pharma (NASDAQ:BBIO) Hits New 1-Year High at $37.03 - Vimarsana News

BridgeBio Pharma (NASDAQ:BBIO) Hits New 1-Year High at $37.03

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) hit a new 52-week high during mid-day trading on Friday . The company traded as high as $37.03 and last traded at $36.34, with a volume of 530472 shares traded. The stock had previously closed at $35.91. Analyst Upgrades and Downgrades BBIO has been the topic of […]

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Average Rating of "Moderate Buy" by Brokerages - Vimarsana News

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Average Rating of "Moderate Buy" by Brokerages

Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) have received a consensus rating of “Moderate Buy” from the thirteen analysts that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. The average […]